Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S B, Willemse"'
Publikováno v:
The Netherlands journal of medicine. 78(6)
Successful treatment of chronic hepatitis C with direct-acting antiviral agents (DAAs) is expected to lead to improvement in liver fibrosis in most of the patients. However, limited data are available on the improvement of advanced liver fibrosis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e588cb3c85e3b27b123a159f733a9cf7
https://pubmed.ncbi.nlm.nih.gov/33380534
https://pubmed.ncbi.nlm.nih.gov/33380534
Autor:
M, van Dijk, P A M, Kracht, J E, Arends, H, Blokzijl, D M, Burger, K J, van Erpecum, B, van Hoek, R J, de Knegt, D, Posthouwer, D, Ramsoekh, B J A, Rijnders, J, Schinkel, S B, Willemse, M, van der Valk, J P H, Drenth, On, Behalf Of The HepNed Study Group
Publikováno v:
The Netherlands journal of medicine. 77(4)
Chronic hepatitis C virus (HCV) infection is a global public health issue, which is associated with high rates of morbidity and mortality. The development of direct acting antivirals (DAAs) has transformed treatment: they offer us highly-effective th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c155618ebdf5373a61a82203f443ebb9
https://pubmed.ncbi.nlm.nih.gov/31502544
https://pubmed.ncbi.nlm.nih.gov/31502544
Publikováno v:
Bone marrow transplantation, 52(4), 622-624. Nature Publishing Group
Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc3cb510384070423b23e0a94125f013
https://pure.amc.nl/en/publications/hepatitis-e-virus-infection-and-hepatic-gvhd-in-allogeneic-hematopoietic-stem-cell-transplantation-recipients(5274a5e8-fe7b-469e-94ac-74090afa6236).html
https://pure.amc.nl/en/publications/hepatitis-e-virus-infection-and-hepatic-gvhd-in-allogeneic-hematopoietic-stem-cell-transplantation-recipients(5274a5e8-fe7b-469e-94ac-74090afa6236).html
Autor:
S B, Willemse, D, Razavi-Shearer, F R, Zuure, I K, Veldhuijzen, E A, Croes, A J, van der Meer, D K, van Santen, J M, de Vree, R J, de Knegt, H L, Zaaijer, H W, Reesink, M, Prins, H, Razavi
Publikováno v:
The Netherlands journal of medicine. 73(9)
Prevalence of hepatitis C virus (HCV) infection in the Netherlands is low (anti-HCV prevalence 0.22%). All-oral treatment with direct-acting antivirals (DAAs) is tolerable and effective but expensive. Our analysis projected the future HCV-related dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76b9a46c35fcb5b0503a8582bb409399
https://pubmed.ncbi.nlm.nih.gov/26582807
https://pubmed.ncbi.nlm.nih.gov/26582807
Publikováno v:
The Netherlands journal of medicine. 72(8)
Interferon-g-inducible protein-10 (IP-10) serum levels are associated with IL28B genotype and may predict response to interferon÷ribavirin-based therapy in chronic hepatitis C patients. Our aim was to relate IP-10 levels before and during treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::862bc57a6c0738eff2830b741070d4b0
https://pubmed.ncbi.nlm.nih.gov/25387553
https://pubmed.ncbi.nlm.nih.gov/25387553